Allergen Management

12
Featured Session · 12 of 35

Allergen Management

Food allergies and intolerances drive growing regulatory and product-design demands across the food industry. The session covers precision-fermentation allergens for diagnostic and oral immunotherapy applications, peanut OIT (Palforzia) and emerging milk and egg OIT, allergen labelling regulations (FALCPA sesame addition, EU Food Information Regulation), cross-reactivity testing platforms, anti-IgE biologics (omalizumab, tezepelumab) in food allergy, and the rising prevalence epidemiology. Discussion addresses precision component-resolved diagnostics, allergen-free product manufacturing and validation, the role of microbiome in allergy development, school and restaurant policy frameworks, and emerging EPIT (epicutaneous immunotherapy) platforms.

Topics covered in this session
  • Palforzia peanut OIT
  • Recombinant allergen diagnostics
  • FALCPA sesame addition
  • Omalizumab in food allergy
  • Component-resolved diagnostics
  • EPIT platforms
  • Microbiome and allergy
  • School/restaurant policy